These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9284441)

  • 1. [Partial splenic embolization for the treatment of liver cirrhosis with hypersplenism: assessment of clinical response and liver function].
    Numata S; Akagi K; Sakino I; Ogata H; Kawadoko T; Suzuki N; Nomiyama K; Tsuji H; Fujishima M
    Nihon Shokakibyo Gakkai Zasshi; 1997 Aug; 94(8):526-31. PubMed ID: 9284441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis.
    Gu JJ; He XH; Li WT; Ji J; Peng WJ; Li GD; Wang SP; Xu LC
    Acta Radiol; 2012 Oct; 53(8):862-7. PubMed ID: 22855417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].
    Nomiyama K; Akagi K; Watanabe H; Kajiwara E; Sakino I
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):105-9. PubMed ID: 2066049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.
    Noguchi H; Hirai K; Aoki Y; Sakata K; Tanikawa K
    Hepatology; 1995 Dec; 22(6):1682-8. PubMed ID: 7489974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism.
    Sakata K; Hirai K; Tanikawa K
    Hepatogastroenterology; 1996; 43(7):309-18. PubMed ID: 8682485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
    Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Splenic embolization combined with double-mirror method in treatment of cirrhosis with hypersplenism of advanced schistosomiasis patients: a report of 38 cases].
    Zhao S; She HT; Lu Y; Shi JL
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Feb; 25(1):108-9. PubMed ID: 23687833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis of residual spleen after partial splenic embolization for the treatment of hypersplenism in cirrhosis].
    Iida T; Sakino I; Akagi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Mar; 58(4):152-6. PubMed ID: 9584459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.
    Abdella HM; Abd-El-Moez AT; Abu El-Maaty ME; Helmy AZ
    Indian J Gastroenterol; 2010 Mar; 29(2):59-61. PubMed ID: 20443100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial splenic embolization for the treatment of hypersplenism in cirrhosis.
    Sangro B; Bilbao I; Herrero I; Corella C; Longo J; Beloqui O; Ruiz J; Zozaya JM; Quiroga J; Prieto J
    Hepatology; 1993 Aug; 18(2):309-14. PubMed ID: 8340060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
    Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
    Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism.
    Tomikawa M; Akahoshi T; Sugimachi K; Ikeda Y; Yoshida K; Tanabe Y; Kawanaka H; Takenaka K; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2010 Feb; 25(2):397-402. PubMed ID: 19929930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Ishiko T; Baba H
    J Gastroenterol; 2010 May; 45(5):554-9. PubMed ID: 20047119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism.
    He XH; Gu JJ; Li WT; Peng WJ; Li GD; Wang SP; Xu LC; Ji J
    World J Gastroenterol; 2012 Jun; 18(24):3138-44. PubMed ID: 22791950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: does increased hepatic arterial flow induce liver regeneration?
    Liu Q; Ma K; Song Y; Zhou N; He Z
    Surgery; 2008 Apr; 143(4):509-18. PubMed ID: 18374048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis.
    DuBois B; Mobley D; Chick JFB; Srinivasa RN; Wilcox C; Weintraub J
    Clin Imaging; 2019; 54():71-77. PubMed ID: 30553121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol; 2021 Apr; 56(4):382-394. PubMed ID: 33629147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.